This Solicitation opportunity from Washington was posted on October 2, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Medical Diagnostic Testing Services

Closed

06825State & Local

Submission Closed11/11/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

Federal

Laboratory Support Services

Solicitation # HQ0034-26-SS-1019SAM

Washington Headquarters Services

POSTED

DEADLINE

Brucella and Tuberculosis Laboratory TestingThis subcontract involves providing specialized laboratory testing services for the Texas Animal Health Commission to detect Brucella and Tuberculosis infections as part of zoonotic disease surveillance projects. The selected provider will process blood samples within BSL-2 or BSL-3 laboratory facilities and is responsible for delivering all associated test results and reports to the prime contractors. To qualify for this engagement, the provider must maintain CLIA certification and possess the necessary specialized biosafety certifications required for the safe handling of infectious agents. The opportunity is categorized under NAICS code 621511, with a response deadline set for December 10, 2026.

Texas Animal Health Commission

POSTED

DEADLINE

Cholinesterase Testing ServicesThis subcontract for Cholinesterase Testing Services supports Texas Animal Health Commission pesticide exposure monitoring projects. The selected provider will be responsible for processing blood samples to detect cholinesterase levels, performing both baseline and routine surveillance testing. All work must be conducted in a certified diagnostic laboratory using clinical chemistry analyzers, and the provider is required to maintain CLIA certification. The scope of work includes the delivery of detailed laboratory test results and reports for every individual tested. This opportunity falls under NAICS code 621511, with a response deadline set for December 10, 2026.

Texas Animal Health Commission

POSTED

DEADLINE

Regional Phlebotomy and Sample Collection ServicesThe Regional Phlebotomy and Sample Collection Services subcontract involves providing specialized blood draw services for prime contractors supporting Texas Animal Health Commission personnel projects. The selected provider must supply qualified, licensed phlebotomy technicians and physical facilities to conduct sample collections across various locations throughout Texas. The scope of work includes the management of sample handling and preparation using medical-grade collection tubes and cold-chain transport containers to ensure specimen integrity. The provider is responsible for strict compliance with biohazard handling regulations and the secure delivery of all collected blood samples to the designated processing laboratory.

Texas Animal Health Commission

POSTED

DEADLINE

Laboratory Testing Services for Field Personnel

Solicitation # 554-27-002

The Texas Animal Health Commission (TAHC) is soliciting a laboratory testing facility under RFP 554-27-002 to provide phlebotomy and laboratory testing services for field personnel exposed to pesticides. The selected contractor will be responsible for providing physical facilities and staff across multiple Texas locations to conduct baseline and routine surveillance testing for Cholinesterase, Brucella, and Tuberculosis. Key deliverables include the provision of all necessary specimen collection supplies, such as containers, tubes, and bio-hazard containers, as well as the materials required to maintain sample integrity during transit. The contractor must also provide training to TAHC staff and the Medical Review Officer on the proper handling and preparation of specimens. The initial contract term is scheduled from March 1, 2027, through February 29, 2028, with an optional renewal through February 28, 2029. Award decisions will be based on a best value standard, with past performance evaluated on a pass/fail basis. Contractors must comply with various Texas and Federal mandates, including E-Verify, cybersecurity training, and certifications against boycotting Israel. Proposals must be submitted in a sealed container by December 10, 2026, at 2:00 p.m. CT, as email or fax submissions are not accepted. Performance and payment bonds may be required for contracts exceeding $100,000 and $25,000, respectively, and self-insurance is not permitted.

Texas Animal Health Commission

POSTED

DEADLINE

Outsourced Pathology Referral TestingThis subcontract, managed by Supply Chain Coordination Limited, involves the provision of specialized diagnostic testing on a referral basis for prime contractors working on NHS Supply Chain projects. The scope of work focuses on delivering outsourced analysis across high-complexity areas, including genomics, microbiology, cellular pathology, and blood sciences. To ensure clinical quality and competence, the provider must maintain ISO 15189 certification and deliver validated diagnostic test reports for all referred specimens. The opportunity was posted on October 22, 2026, with a response deadline set for December 16, 2026. Classified under NAICS code 621511, the contract is structured as a subcontract to support the broader diagnostic infrastructure of the NHS Supply Chain.

Supply Chain Coordination Limited

POSTED

DEADLINE

End-to-End Pathology and POCT Managed ServicesThis subcontract for End-to-End Pathology and POCT Managed Services, issued by Supply Chain Coordination Limited, focuses on delivering comprehensive diagnostic outcomes for prime contractors on NHS Supply Chain projects. The scope of work encompasses the entire diagnostic cycle, including preanalytical, analytical, and postanalytical phases, to ensure a fully operational managed pathology service. A key objective is the expansion of diagnostic capabilities into neighborhood settings and Community Diagnostic Centres through the implementation of Point of Care Testing devices and integrated workflow systems. The provider is responsible for maintaining strict clinical performance and quality assurance standards across all service areas. Interested parties must note that the response deadline for this opportunity is December 16, 2026. The contract is categorized under NAICS code 621511, emphasizing the specialized medical laboratory nature of the required services.

Supply Chain Coordination Limited

POSTED

DEADLINE

In-Vitro Diagnostics, Point of Care Testing & Pathology Services

Solicitation # Project_1717

Supply Chain Coordination Limited is establishing a National Framework Agreement, identified as Project_1717, for the provision of In-Vitro Diagnostic Devices, Point of Care Testing products, and related pathology services across the United Kingdom. The scope is divided into three lots: Lot 1 focuses on end-to-end Pathology Managed Services to expand diagnostics into community settings; Lot 2 covers Pathology Software Solutions including AI platforms and middleware; and Lot 3 addresses Diagnostics Testing Solutions across various disciplines such as biochemistry, genomics, and haematology. The framework includes the supply of core laboratory equipment, consumables, reagent rental agreements, and specimen storage and collection services. The procurement is structured as an open framework with an overall intended duration of eight years, with the initial term running from October 18, 2027, to October 17, 2029. There is no limit on the number of suppliers who can be appointed. Award criteria vary by lot, with Lot 1 and 2 weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is weighted at 60 percent for quality, 30 percent for cost, and 10 percent for social value. The authority may award contracts through the framework either with or without further competition. Small and medium-sized enterprises, as well as voluntary, community and social enterprises, are eligible to participate. The deadline for tender submissions is December 16, 2026.

Supply Chain Coordination Limited

POSTED

DEADLINE

Prospera Molecular Expression Transplant Assessment TestingThis subcontract involves the provision of proprietary molecular genetic reference testing to support prime contractors on Department of Veterans Affairs projects within VISN 17. The scope of work focuses on executing Prospera molecular expression transplant assessment tests, which utilize proprietary assays and bioinformatics software to analyze genetic markers for the purpose of monitoring transplant patients. All services must adhere to CPT Code 81479 and culminate in the delivery of comprehensive molecular test results and reports. The project is managed under the Department of Veterans Affairs Network Contract Office 17 and is classified under NAICS code 621511. Interested parties should note the response deadline of October 30, 2026, for this specialized medical diagnostic requirement.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Signatera Residual Disease Testing ServicesThis subcontract involves the provision of proprietary molecular genetic reference testing for prime contractors supporting Department of Veterans Affairs VISN 17 projects. The scope of work focuses on the execution of Signatera Residual Disease Tests and non-liquid biopsy tumor typing, utilizing specialized bioinformatics platforms, assays, and reagents. These services are specifically designed for cancer residual disease monitoring and must adhere to CPT Codes 81479 and 81455. Managed under NAICS code 621511, the contract requires the delivery of comprehensive molecular test results and detailed reports. The project is overseen by the Department of Veterans Affairs Network Contract Office 17, with a response deadline set for October 30, 2026.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Q301--NEW â€“ STX Specialized Molecular Residual Disease Testing

Solicitation # 36C25727Q0058

The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole-source, Indefinite Delivery Indefinite Quantity (IDIQ) Firm-Fixed-Price contract to Natera, Inc. for proprietary molecular genetic reference testing services. These services are essential for evaluating and monitoring transplant patients and cancer residual disease through the use of the Prospera molecular expression transplant assessment test and the Signatera Residual Disease Test (MRD). The government has identified Natera, Inc. as the sole provider because they possess the exclusive proprietary methodologies, assays, and bioinformatics platforms required to perform these specific tests, with no authorized distributors or alternative clinical sources available. The scope of work includes an estimated quantity of 35 Signatera tests (CPT Codes 81479, 81455) and 25 Prospera tests (CPT Code 81479). The contract will span five ordering periods, with performance taking place at VA facilities within VISN 17 in Texas. While this notice is not a formal request for quotes, interested parties may submit capability statements to Susan Flores by November 2, 2026, to demonstrate the existence of an equivalent proprietary test. The government retains discretion on whether to compete the requirement based on the responses received.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Comprehensive Drug Screening and Laboratory AnalysisThis subcontract for Comprehensive Drug Screening and Laboratory Analysis involves providing clinical collection and laboratory analysis of biological samples for prime contractors on ALEA drug screening projects. The scope of work includes conducting hair analysis and Non-NIDA Panel 8 testing, utilizing specialized clinical laboratory equipment and strict Chain of Custody forms to ensure accuracy and compliance. Beyond technical analysis, the provider is responsible for the medical review of non-negative results and the delivery of confirmed drug screen reports. The contract also encompasses the management of centralized billing and administrative functions to support the overall drug screening operation for the Alabama Personnel agency.

Personnel

POSTED

2 days ago

DEADLINE

in 4 days

General Info

Agency

Washington Department of Enterprise Services (DES)

NAICS

621511 - Medical Laboratories

Place of Performance

WA, USA

Set-Aside

NONE

Documents

06825 Competitive Solicitation

11 pages · rfp

High

06825 Exhibit C - Medical Diagnostic Testing Services Price Sheet

specifications

High

06825 Medical Diagnostic Testing Services Exhibit C Price Sheet

9 pages · other

High

06825 Medical Diagnostic Testing Services Pre-Bid Conference

industry-day

High

06825 Medical Diagnostic Testing Services - Q&A #1

q-and-a

High

06825 Medical Diagnostic Testing Services - Question & Answer #2

q-and-a

High

Competitive Solicitation No. 06825 - Statewide Medical Diagnostic Testing Services

rfp

High

Competitive Solicitation No. 06825 - Statewide Medical Diagnostic Testing Services

rfp

High

Solicitation 06825 Amendment 1 - Medical Diagnostic Testing Services

amendment

High

Solicitation 06825 Amendment 2 - Medical Diagnostic Testing Services

amendment

High

Solicitation 06825 Amendment No. 3 - Medical Diagnostic Testing Services

amendment

High

06825 Exhibit A - Bidder's Certification

11 pages · other

Low

06825 Exhibit B - Scored Non-Cost Factors for Medical Diagnostic Testing Services

6 pages · other

Low

06825 Exhibit D Statewide Contract

29 pages · contract-document

Low

06825 Exhibit E-Diverse Business Inclusion Plan

4 pages · other

Low

Contract No. 06825 - Statewide Medical Diagnostic Testing Services

contract-document

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseClosed

PostedJul 31

Solicitation

Notice updatedOct 2

Response deadline changed from Aug 28, 2025 to Nov 11, 2025. The notice title changed. NAICS code changed from 237310 to 621511. The notice description changed. The point of contact changed.

Deadline changedOct 2

Response deadline changed from Nov 11, 2025 to Nov 6, 2025.

Response DeadlineNov 11

Deadline has passed

Submission Closed

11/11/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyWashington Department of Enterprise Services (DES)

Contacts1 person available

OfficeN/A

Organization / AgencyWashington Department of Enterprise Services (DES)

Office AddressN/A

Contacts

Brad Stringfellow

contact@example.gov

+1 (555) 000-0000

Full Description

Enterprise Services is soliciting bids from qualified Bidders to provide medical diagnostic testing services. The scope of the solicitation includes: specimen pickup, phlebotomy services, pathology service testing and interpretation of lab results. There will be a single category Market Basket with weighted results using prior purchasing history. Any Bidder wishing to participate must be an MTS or CLIA accredited testing facility.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS